Form 4: Capricor Therapeutics CEO Linda Marban Reports Stock Transactions
SEC Form 4 Filing
Linda Marban, CEO of Capricor Therapeutics, reports the acquisition and disposal of common stock and derivative securities.
Summary
- Linda Marban, the CEO of Capricor Therapeutics, filed a Form 4 detailing changes in beneficial ownership.
- On March 3, 2025, she acquired 25,000 shares of common stock at $1.39 per share through the exercise of stock options.
- On March 5, 2025, she disposed of 12,500 shares of common stock at $0, transferring them to her ex-spouse as part of a divorce settlement.
- Following these transactions, Marban directly owns 211,104 shares of Capricor Therapeutics common stock.
- She also exercised options for 25,000 shares at a price of $0.
- The stock option was originally granted on March 3, 2015, for 250,000 shares at $5.78 per share, but was adjusted due to a 1-for-10 reverse split on June 4, 2019, and a share reprice to $1.39 on February 12, 2020.
- The shares vested 1/48th monthly starting April 1, 2015.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by the CEO. The sentiment is neutral as it primarily reflects personal financial activity (divorce settlement) and routine option exercises.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, like the CEO, which can be an indicator of their confidence in the company's prospects. The transfer of shares due to a divorce settlement is a personal matter and may not reflect the CEO's view on the company's future.
Comparison to Industry Standards
- Form 4 filings are a regulatory requirement for all publicly traded companies in the United States, ensuring transparency in insider trading activities.
- The details provided in this Form 4 are consistent with the standard reporting practices required by the SEC.
- Comparable companies would also be required to file similar reports when their executives engage in transactions involving the company's securities.
Stakeholder Impact
- Shareholders may be interested in the CEO's trading activity as an indicator of confidence in the company.
- The transfer of shares to an ex-spouse is unlikely to have a direct impact on other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 03/03/2015 | Date stock option was granted. |
| 04/01/2015 | Commencement date for monthly vesting of shares (1/48th per month). |
| 06/04/2019 | Date of 1-for-10 reverse stock split. |
| 02/12/2020 | Date of share reprice to $1.39 per share. |
| 03/03/2025 | Date of common stock acquisition via stock option exercise. |
| 03/05/2025 | Date of common stock disposal due to divorce settlement. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.